La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
UFP Technologies Résultats passés
Passé contrôle des critères 2/6
UFP Technologies has been growing earnings at an average annual rate of 28%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 20.2% per year. UFP Technologies's return on equity is 16%, and it has net margins of 11.9%.
Informations clés
28.0%
Taux de croissance des bénéfices
27.4%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 8.9% |
| Taux de croissance des recettes | 20.2% |
| Rendement des fonds propres | 16.0% |
| Marge nette | 11.9% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
UFP Technologies, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Aug 03
There's Reason For Concern Over UFP Technologies, Inc.'s (NASDAQ:UFPT) Massive 27% Price Jump
Jul 17The Return Trends At UFP Technologies (NASDAQ:UFPT) Look Promising
Jul 12UFP Technologies: Impressive Has Become Expensive
Jul 02Is UFP Technologies (NASDAQ:UFPT) A Risky Investment?
Jun 22Unpleasant Surprises Could Be In Store For UFP Technologies, Inc.'s (NASDAQ:UFPT) Shares
May 30Should You Be Adding UFP Technologies (NASDAQ:UFPT) To Your Watchlist Today?
Apr 11At US$241, Is UFP Technologies, Inc. (NASDAQ:UFPT) Worth Looking At Closely?
Mar 27UFP Technologies (NASDAQ:UFPT) Is Looking To Continue Growing Its Returns On Capital
Mar 15US$231 - That's What Analysts Think UFP Technologies, Inc. (NASDAQ:UFPT) Is Worth After These Results
Feb 24UFP Technologies, Inc.'s (NASDAQ:UFPT) 29% Price Boost Is Out Of Tune With Earnings
Feb 22An Intrinsic Calculation For UFP Technologies, Inc. (NASDAQ:UFPT) Suggests It's 24% Undervalued
Jan 31UFP Technologies (NASDAQ:UFPT) Has A Rock Solid Balance Sheet
Jan 18Some Confidence Is Lacking In UFP Technologies, Inc.'s (NASDAQ:UFPT) P/E
Jan 03Is UFP Technologies, Inc. (NASDAQ:UFPT) Potentially Undervalued?
Dec 11There's Been No Shortage Of Growth Recently For UFP Technologies' (NASDAQ:UFPT) Returns On Capital
Oct 05Should You Think About Buying UFP Technologies, Inc. (NASDAQ:UFPT) Now?
Aug 05These 4 Measures Indicate That UFP Technologies (NASDAQ:UFPT) Is Using Debt Reasonably Well
Jul 18UFP Technologies, Inc. (NASDAQ:UFPT) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 15Here's Why We Think UFP Technologies (NASDAQ:UFPT) Is Well Worth Watching
May 04Is UFP Technologies (NASDAQ:UFPT) A Risky Investment?
Apr 14UFP Technologies (NASDAQ:UFPT) Is Doing The Right Things To Multiply Its Share Price
Mar 22Calculating The Intrinsic Value Of UFP Technologies, Inc. (NASDAQ:UFPT)
Feb 18Should You Be Adding UFP Technologies (NASDAQ:UFPT) To Your Watchlist Today?
Jan 27Returns On Capital Are Showing Encouraging Signs At UFP Technologies (NASDAQ:UFPT)
Dec 19UFP Technologies' (NASDAQ:UFPT) Earnings Are Of Questionable Quality
Nov 17UFP Technologies (NASDAQ:UFPT) Seems To Use Debt Quite Sensibly
Nov 03Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 29% Discount?
Sep 27UFP Technologies (NASDAQ:UFPT) Seems To Use Debt Rather Sparingly
Aug 03UFP Technologies GAAP EPS of $1.17 beats by $0.43, revenue of $94.34M beats by $18.44M
Aug 02UFP technologies sells molded fiber business to CKF for $32M
Jul 27Results: UFP Technologies, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 07Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 29% Discount?
Aug 05Here's Why Shareholders May Want To Be Cautious With Increasing UFP Technologies, Inc.'s (NASDAQ:UFPT) CEO Pay Packet
Jun 03Is It Time To Consider Buying UFP Technologies, Inc. (NASDAQ:UFPT)?
May 28There Are Reasons To Feel Uneasy About UFP Technologies' (NASDAQ:UFPT) Returns On Capital
May 10Ventilation des recettes et des dépenses
Comment UFP Technologies gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 417 | 50 | 53 | 0 |
| 31 Mar 24 | 407 | 48 | 52 | 0 |
| 31 Dec 23 | 400 | 45 | 51 | 0 |
| 30 Sep 23 | 390 | 42 | 50 | 0 |
| 30 Jun 23 | 386 | 50 | 49 | 0 |
| 31 Mar 23 | 380 | 47 | 49 | 0 |
| 31 Dec 22 | 354 | 42 | 46 | 0 |
| 30 Sep 22 | 319 | 37 | 42 | 0 |
| 30 Jun 22 | 273 | 21 | 37 | 0 |
| 31 Mar 22 | 229 | 17 | 32 | 0 |
| 31 Dec 21 | 206 | 16 | 29 | 0 |
| 30 Sep 21 | 195 | 17 | 28 | 0 |
| 30 Jun 21 | 188 | 16 | 28 | 0 |
| 31 Mar 21 | 180 | 14 | 27 | 0 |
| 31 Dec 20 | 179 | 13 | 27 | 0 |
| 30 Sep 20 | 184 | 15 | 28 | 0 |
| 30 Jun 20 | 191 | 18 | 29 | 0 |
| 31 Mar 20 | 199 | 20 | 30 | 0 |
| 31 Dec 19 | 198 | 20 | 29 | 0 |
| 30 Sep 19 | 199 | 18 | 29 | 0 |
| 30 Jun 19 | 197 | 17 | 29 | 0 |
| 31 Mar 19 | 195 | 16 | 28 | 0 |
| 31 Dec 18 | 190 | 14 | 28 | 0 |
| 30 Sep 18 | 177 | 13 | 26 | 0 |
| 30 Jun 18 | 165 | 10 | 25 | 0 |
| 31 Mar 18 | 154 | 9 | 24 | 0 |
| 31 Dec 17 | 148 | 9 | 24 | 0 |
| 30 Sep 17 | 147 | 8 | 24 | 0 |
| 30 Jun 17 | 149 | 9 | 24 | 0 |
| 31 Mar 17 | 149 | 9 | 25 | 0 |
| 31 Dec 16 | 146 | 8 | 24 | 0 |
| 30 Sep 16 | 144 | 8 | 24 | 0 |
| 30 Jun 16 | 141 | 7 | 24 | 0 |
| 31 Mar 16 | 139 | 7 | 24 | 0 |
| 31 Dec 15 | 139 | 8 | 24 | 0 |
| 30 Sep 15 | 140 | 7 | 24 | 0 |
| 30 Jun 15 | 141 | 8 | 24 | 0 |
| 31 Mar 15 | 139 | 7 | 24 | 0 |
| 31 Dec 14 | 139 | 8 | 24 | 0 |
| 30 Sep 14 | 139 | 9 | 24 | 0 |
| 30 Jun 14 | 138 | 10 | 24 | 0 |
| 31 Mar 14 | 140 | 11 | 24 | 0 |
| 31 Dec 13 | 139 | 11 | 24 | 0 |
| 30 Sep 13 | 138 | 11 | 23 | 0 |
Des revenus de qualité: UFPT has high quality earnings.
Augmentation de la marge bénéficiaire: UFPT's current net profit margins (11.9%) are lower than last year (12.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: UFPT's earnings have grown significantly by 28% per year over the past 5 years.
Accélération de la croissance: UFPT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: UFPT had negative earnings growth (-0.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.5%).
Rendement des fonds propres
ROE élevé: UFPT's Return on Equity (16%) is considered low.